Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapnetin capsules for lower-extremity varicose veins with superficial thrombophlebitis
ChiCTR2500095975Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Medical University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of daphnetin in Varicose veins of lower extremities (VVLE) and Superficial Phlebitis (2 arms), sponsored by The Second Affiliated Hospital of Xi'an Medical University. Primary endpoint: Venous Clinical Severity Score at week 12. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
daphnetin
03
Conditions
Varicose veins of lower extremities (VVLE)Superficial Phlebitis
Beyond the preview
Go deeper on ChiCTR2500095975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095975.